$ANIK Company News Two names for a two-way stock market

New Post Public Reply Private Reply Replies (0) Message Board

May 9, 2014 at 12:15 PM

$ANIK Company News

Two names for a two-way stock market 2:42 p.m. May 8, 2014 - The Trading Deck
Nasdaq treads water while a few names show their stuff 2:36 p.m. May 6, 2014 - The Trading Deck
Dow edges to less-charted technical territory 11:48 a.m. May 1, 2014 - Michael Ashbaugh
Dow edges to less-charted territory 11:27 a.m. May 1, 2014 - Michael Ashbaugh
S&P 500 extends the break to ‘clear skies’ territory 11:46 a.m. March 6, 2014 - Michael Ashbaugh
Stock futures edge higher ahead of home sales 9:11 a.m. Feb. 26, 2014 - William L. Watts
First Solar shares burned as earnings disappoint 7:05 p.m. Feb. 25, 2014 - Wallace Witkowski
Amgen boosts biotech sector to close up 6:23 p.m. March 11, 2011 - Wallace Witkowski
Human Genome rallies against biotech downturn 6:04 p.m. March 10, 2011 - Wallace Witkowski
Illumina dives, Anika rallies on earnings reports 11:53 a.m. Oct. 28, 2009 - Val Brickates Kennedy
Genzyme, Merck lead as drug stocks move higher 1:04 p.m. Aug. 21, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 5:07 p.m. Aug. 20, 2009 - MarketWatch
Drug stocks gain; Anika zooms on drug approval 12:32 p.m. Aug. 20, 2009 - Val Brickates Kennedy
Wednesday's biggest stock gainers and decliners 5:27 p.m. July 25, 2007 - Gabriel Madway
Stocks in focus for Wednesday 7:37 p.m. July 24, 2007 - MarketWatch
Friday's biggest stock gainers and decliners 4:42 p.m. April 13, 2007 - Michael Baron
Stocks in focus Friday 7:14 p.m. April 12, 2007 - Katherine Hunt
Anika Therapeutics receives CE Mark approval for Elevess 5:30 p.m. April 12, 2007 - Katherine Hunt
Anika Therapeutics up 5.3% at $14.10 10:46 a.m. Dec. 21, 2006 - Tomi Kilgore
Anika Thera gets FDA approval for cosmetic tissue augment 9:52 a.m. Dec. 21, 2006 - Thomas Middleton

Focus On Anika Therapeutics 6:09 a.m. May 8, 2014 - Seeking Alpha
10-Q: ANIKA THERAPEUTICS, INC. 5:30 p.m. May 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Insider Trading Alert - ANIK, TRLA And AMED Traded By Insiders 10:15 a.m. May 5, 2014 - TheStreet.com
Anika Therapeutics' CEO Discusses Q1 2014 Results - Earnings Call Transcript 4:04 p.m. April 30, 2014 - Seeking Alpha
Notable earnings after Tuesday’s close 5:35 p.m. April 28, 2014 - Seeking Alpha
Some IBD 50 Stocks May Be Forming Bases 5:42 p.m. April 25, 2014 - Investors Business Daily
Facebook, Arris, Grifols Initiate New Bases 5:35 p.m. April 11, 2014 - Investors Business Daily
Biotech IPOs Adamas, Cerulean Slump In Trading Debut 3:02 p.m. April 10, 2014 - Investors Business Daily
PolyOne, Anika, Methode Among The Leading Small Caps 7:02 a.m. April 10, 2014 - Investors Business Daily
Biotechs, Medicals Get Hurt Amid Price-Inquiry News 5:26 p.m. March 21, 2014 - Investors Business Daily
10-K: ANIKA THERAPEUTICS INC 5:29 p.m. March 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Mutual Funds Loading Up On These 3 Top-Rated Stocks 7:02 a.m. March 7, 2014 - Investors Business Daily
Insider Trading Alert - SWK, ANIK And NYT Traded By Insiders 10:15 a.m. March 4, 2014 - TheStreet.com
Anika Therapeutics (ANIK) Showing Signs Of A Dead Cat Bounce Today 9:55 a.m. March 3, 2014 - TheStreet.com
Cramer's Mad Money - 10 Biggest Gains (2/27/14) 6:22 a.m. Feb. 28, 2014 - Seeking Alpha
Anika Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:43 p.m. Feb. 27, 2014 - Seeking Alpha
Anika Therapeutics (ANIK) In A Perilous Reversal 9:46 a.m. Feb. 27, 2014 - TheStreet.com
Mid-Day Market Update: First Solar Falls On Downbeat Results; Anika Therapeutics Shares Jump 11:52 a.m. Feb. 26, 2014 - benzinga.com
Anika Arthritis Drug Approval Sends Stock Soaring 10:47 a.m. Feb. 26, 2014 - Investors Business Daily
Benzinga's Volume Movers 9:37 a.m. Feb. 26, 2014 - benzinga.com

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 6:32 p.m. May 7, 2014 - PR Newswire - PRF
Anika Therapeutics Reports First Quarter 2014 Financial Results 4:08 p.m. April 29, 2014 - BusinessWire - BZX
Anika Therapeutics Announces Date of First-Quarter 2014 Financial Results Conference Call 5:09 p.m. April 16, 2014 - BusinessWire - BZX
Anika Therapeutics Announces First U.S. Commercial Sale of Monovisc® 2:31 p.m. April 15, 2014 - BusinessWire - BZX
Anika Therapeutics Announces Dismissal of MONOVISC® U.S. Patent Infringement Lawsuit 8:55 a.m. March 13, 2014 - BusinessWire - BZX
Anika Therapeutics to Present at Canaccord Genuity Musculoskeletal Conference March 11 5:06 p.m. March 4, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 12:35 p.m. Feb. 27, 2014 - PR Newswire - PRF
Chesapeake Energy Falls after Missing Estimates; Anika Therapeutics Gets FDA Approval for Monovisc 2:16 a.m. Feb. 27, 2014 - ACCESSWIRE
Anika Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 5:06 p.m. Feb. 26, 2014 - BusinessWire - BZX
FDA Approves MONOVISC®, A New Single Injection Treatment for Treatment of Pain Due to Osteoarthritis of the Knee 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2013 Financial Results Conference Call 5:06 p.m. Feb. 12, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 11:11 a.m. Feb. 12, 2014 - PR Newswire - PRF
Anika Therapeutics to Present at the Tenth Annual Noble Financial Equity Conference on January 20 5:40 p.m. Jan. 9, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 9:00 a.m. Dec. 24, 2013 - PR Newswire
Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis 9:00 a.m. Dec. 3, 2013 - PR Newswire
FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics 9:00 a.m. Nov. 25, 2013 - PR Newswire
Allegion plc Set to Join the S&P 500; J.C. Penney to Join S&P MidCap 400; Aeropostle, Anika Therapeutics to Join S&P SmallCap 600 6:47 p.m. Nov. 22, 2013 - PR Newswire
Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences 9:00 a.m. Nov. 6, 2013 - PR Newswire
Anika Therapeutics Reports 20% Total Revenue Growth and Record Third-Quarter Earnings 4:05 p.m. Oct. 30, 2013 - BusinessWire
Anika Therapeutics Announces Date of Third-Quarter 2013 Financial Results Conference Call 8:30 a.m. Oct. 15, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...